
|Podcasts|October 4, 2022
Transforming CMC Dossier Creation
Author(s)Dassault Systèmes BIOVIA
Through the adoption of a data driven and automated CMC Dossier generation process, pharmaceutical companies can reduce time-to-market while delivering significant cost savings to the organization. Eliminate errors, duplicate data entry and verification, create a digital chain of evidence and significantly reduce time spent on CMC authoring.
Trending on Pharmaceutical Technology
1
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
2
GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy
3
European Biotechs Reshaping Respiratory Disease
4
FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 1
5



